The absence of DNAM-1 on donor Treg promotes regulatory function in vivo. (A) Representative FACS plots of the sort strategy on CD25+CD8− T cells from naive B6.WT or B6.DNAM-1−/− mice and Foxp3 expression on sorted cells. (B) 5 × 106 BM from B6.WT mice with or without 0.2 × 106 FACS sort-purified CD25+CD4+ T cells from B6.WT or B6.DNAM-1−/− mice were transplanted into lethally irradiated BALB/c mice. Two days later, those recipients were given 0.5 × 106 CD3+ T cells from CD25 Ab–treated B6.WT mice. TCD bone marrow from B6.WT donors was transplanted into irradiated BALB/c recipients as non-GVHD controls. Survival data are shown. P < .0001, B6.DNAM-1−/− Treg vs no Treg; P = .0001, B6.WT Treg vs no Treg; P = .0011, B6.WT Treg vs B6.DNAM-1−/− Treg. Data shown are combined from 3 replicate experiments (n = 16 T-cell–replete group without Treg, n = 22 per T-cell–replete group with Treg, and n = 9 in TCD control). (C) 5 × 106 BM from B6.WT mice with or without 0.4 × 106 FACS sort-purified CD25+CD4+ T cells from B6.WT or B6.DNAM-1−/− mice were transplanted into lethally irradiated B6D2F1 mice. Seven days later, those recipients were given 2 × 106 CD3+ carboxyfluorescein succinimidyl ester (CFSE)–labeled T cells from CD25 Ab–treated B6 (CD45.1+) mice. Four days later, spleens from recipients were analyzed. CD45.1+IFN-γ+CD4+ T cells (CD45.1+CD3+CD4+) (top right) and CD45.1+IFN-γ+CD8+ T cells (CD45.1+CD3+CD8+) (bottom right). Representative FACS plots for CFSE dilution and IFN-γ secretion in CD4+ and CD8+ T cells from each group are shown. IFN-γ+CD4+ T cells: P = .016, B6.DNAM-1−/− Treg vs no Treg; P = .029, B6.WT Treg vs no Treg; P = .016, B6.WT Treg vs B6.DNAM-1−/− Treg. IFN-γ+CD8+ T cells; P = .016, B6.DNAM-1−/− Treg vs no Treg; P = .029, B6.WT Treg vs no Treg; P = .064, B6.WT Treg vs B6.DNAM-1−/− Treg. n = 4 to 5 per group. Representative data from 1 of 2 experiments is shown.